|
|
|
| home > white papers > Key to Outsourcing Method Development and Validation A Pragmatic Approach - RSSL |
|
|
 WHITE PAPERS |
|
RSSL
|
+44 (0)118 918 4024
|
|
http://www.rssl.com
|
|
University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA
|
|
|
Key to Outsourcing Method Development and Validation A Pragmatic Approach
|
|
In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
GENEVA, 23 March 2022 – STALICLA, a Swiss clinical stage biotech
company leading omics-based drug development for patients with
neurodevelopmental disorders (NDDs), announced today the highly
successful completion of the phase 1b trials for its lead drug candidate
STP1. These clinical data clear the way for a first application of
STALICLA’s precision medicine discovery platform in autism spectrum
disorders.
More info >> |
|
 |
White Papers |
 |
|
Running Smarter Trials With Data-Driven Monitoring
PAREXEL
Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm. Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >> |
|
|
|
